NASDAQ: ANIK
$41.95
+ 0.17 (0.41%)
Volume: 44,500
10:43 AM ET on Aug 27, 2014
Delayed at least 20 minutes.

Investor Relations

Headquartered in Bedford, Mass., Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products for tissue protection, healing, and repair. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. Anika's products range from orthopedic/joint health solutions led by Orthovisc®, a treatment for osteoarthritis of the knee; to surgical aids in the ophthalmic and anti-adhesion fields. The company also offers aesthetic dermal fillers for the correction of facial wrinkles. Anika's Italian subsidiary, Anika Therapeutics, S.r.l, provides complementary HA products in orthopedic/joint health and anti-adhesion, as well as therapeutics in new areas such as advanced wound treatment and ear, nose and throat care. Its regenerative tissue technology advances Anika's vision to offer therapeutic products that go beyond pain relief to protect and restore damaged tissue.

 News Releases

News Releases

View recent and archived news releases on acquisitions, earnings, events and general company news

Corporate Governance

Corporate Governance

View recent and archived news releases on acquisitions, earnings, events and general company news

 Webcasts & Presentations

Webcasts & Presentations

Listen to quarterly earnings calls and investor conference presentations.

Quarterly Results

Financial Results

Download quarterly earnings releases and other related documents.

 SEC Filings

SEC Filings

Download reader-friendly documents and access all SEC filings.

Stock Information

Stock Information

Access stock quotes and charts.